Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
UBN Relief
- Development stage
- Preclinical
- Lead developer
- Healthy Extracts
- Administration
- Oral
01
Overview
UBN Relief is an orally administered nutraceutical dietary supplement developed by Healthy Extracts for migraine management. It is described as a proprietary, patent-protected medium chain triglyceride based nootropic formulation containing highly concentrated naturally derived medium chain triglycerides produced through a patent-pending extraction process together with phytonutrients, and it is marketed as caffeine-free and without added sugar. Based on the provided information, the product is intended to reduce migraine frequency and duration and may also improve cognitive function, sleep satisfaction, and quality of life after daily use over 60 days. Its precise molecular mechanism of action and discrete biological targets are not clearly defined in the provided material, so it is best characterized as a multi-ingredient nutraceutical formulation rather than a pharmaceutical drug.
- Brand names
- UBN Relief
- Other names
- UBN RELIEF
Beyond the preview
Go deeper on UBN Relief.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on UBN Relief.